Published in J Am Soc Nephrol on March 23, 2005
Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance | NCT01545531
Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70
Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85
In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int (2010) 2.82
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2006) 2.61
Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol (2012) 2.58
Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol (2009) 2.43
High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care (2010) 2.12
Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol (2009) 2.10
Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med (2007) 1.94
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. J Am Soc Nephrol (2007) 1.92
Racial and ethnic differences in kidney function decline among persons without chronic kidney disease. J Am Soc Nephrol (2011) 1.87
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis (2010) 1.84
Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2012) 1.79
New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79
Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis. Circulation (2013) 1.65
Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). BMC Nephrol (2008) 1.64
Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care (2013) 1.62
Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol (2008) 1.62
Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis (2008) 1.60
Linkage analysis of glomerular filtration rate in American Indians. Kidney Int (2008) 1.59
Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study. Diabetes Care (2013) 1.58
Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant (2009) 1.46
Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol (2008) 1.44
HIV viremia and changes in kidney function. AIDS (2009) 1.32
Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol (2008) 1.31
Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). J Am Coll Cardiol (2009) 1.30
A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. Clin J Am Soc Nephrol (2008) 1.29
Cystatin C as a marker of cognitive function in elders: findings from the health ABC study. Ann Neurol (2008) 1.24
Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail (2006) 1.21
Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol (2009) 1.19
Cystatin C--a paradigm of evidence based laboratory medicine. Clin Biochem Rev (2008) 1.17
Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol (2011) 1.14
Association of cystatin C with adverse outcomes. Curr Opin Nephrol Hypertens (2009) 1.11
The applicability of eGFR equations to different populations. Nat Rev Nephrol (2013) 1.10
Chronic kidney disease screening methods and its implication for Malaysia: an in depth review. Glob J Health Sci (2015) 1.09
Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Kidney Dis (2013) 1.07
Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis (2013) 1.06
Cystatin C: a step forward in assessing kidney function and cardiovascular risk. Heart Fail Rev (2012) 1.06
Early renal function decline in type 2 diabetes. Clin J Am Soc Nephrol (2011) 1.04
Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project. Am J Kidney Dis (2010) 1.03
Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. Clin J Am Soc Nephrol (2011) 1.00
Longitudinal changes in estimated and measured GFR in type 1 diabetes. J Am Soc Nephrol (2013) 0.98
Cystatin C, kidney function and cardiovascular disease. Pediatr Nephrol (2006) 0.98
Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study. Am Heart J (2012) 0.97
The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study. Hum Genet (2010) 0.96
Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol (2013) 0.94
Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes. Diabetes Care (2011) 0.93
Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis. Nephrol Dial Transplant (2010) 0.92
Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration. Haematologica (2009) 0.92
Early nephropathy in type 1 diabetes: the importance of early renal function decline. Curr Opin Nephrol Hypertens (2009) 0.92
Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study. J Nephrol (2009) 0.91
Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. Kidney Int (2013) 0.90
Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations. Nephrol Dial Transplant (2010) 0.89
The association of pioglitazone and urinary tract disease in type 2 diabetic Taiwanese: bladder cancer and chronic kidney disease. PLoS One (2014) 0.88
Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes. Diabetes Technol Ther (2010) 0.88
Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study. Am J Kidney Dis (2010) 0.87
Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int (2016) 0.85
Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. Clin J Am Soc Nephrol (2015) 0.84
Age and sex influence cystatin C in adolescents with and without type 1 diabetes. Diabetes Care (2011) 0.84
The Protective Effects of Cobra Venom from Naja naja atra on Acute and Chronic Nephropathy. Evid Based Complement Alternat Med (2013) 0.84
Kidney function and clinical recommendations of drug dose adjustment in geriatric patients. BMC Geriatr (2013) 0.83
Estimating glomerular filtration rate in diabetes using serum cystatin C. Clin Biochem Rev (2011) 0.83
Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2). Am J Nephrol (2011) 0.82
Proteomic discovery of diabetic nephropathy biomarkers. Adv Chronic Kidney Dis (2010) 0.82
Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians. Int J Nephrol (2014) 0.82
Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome. Int J Nephrol (2011) 0.81
Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease. Exp Diabetes Res (2012) 0.81
Therapeutic Modalities in Diabetic Nephropathy: Future Approaches. Open J Nephrol (2012) 0.81
Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study. BMC Nephrol (2014) 0.81
Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial. Clin J Am Soc Nephrol (2014) 0.80
Risks of rapid decline renal function in patients with type 2 diabetes. World J Diabetes (2014) 0.80
Neutrophil gelatinase-associated lipocalin in kidney transplantation is an early marker of graft dysfunction and is associated with one-year renal function. J Transplant (2013) 0.79
Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathies. BMC Nephrol (2009) 0.79
Short-term use of adaptive servo ventilation improves renal function in heart failure patients with sleep-disordered breathing. Heart Vessels (2012) 0.79
Effect of enhanced external counterpulsation treatment on renal function in cardiac patients. BMC Nephrol (2013) 0.78
Reduced cystatin C-estimated GFR and increased creatinine-estimated GFR in comparison with iohexol-estimated GFR in a hyperthyroid patient: a case report. J Med Case Rep (2008) 0.78
Biomarkers in diabetic nephropathy: Present and future. World J Diabetes (2014) 0.78
Early detection of diabetic kidney disease: Present limitations and future perspectives. World J Diabetes (2016) 0.78
Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up. J Am Soc Nephrol (2015) 0.77
Estimating GFR in adult patients with hematopoietic cell transplant: comparison of estimating equations with an iohexol reference standard. Clin J Am Soc Nephrol (2015) 0.77
Is cystatin C an important prognostic marker independent of renal function? J Am Coll Cardiol (2010) 0.76
Correlation between cystatin C-based formulas, Schwartz formula and urinary creatinine clearance for glomerular filtration rate estimation in children with kidney disease. J Renal Inj Prev (2016) 0.76
Diabetic nephropathy: What does the future hold? Int Urol Nephrol (2015) 0.75
The efficacy of the cystatin C based glomerular filtration rate in the estimation of safe contrast media volume. Korean Circ J (2013) 0.75
The relationship of ADC values of renal parenchyma with CKD stage and serum creatinine levels. Eur J Radiol Open (2015) 0.75
Higher cystatin C levels are associated with neurocognitive impairment in older HIV+ adults. J Acquir Immune Defic Syndr (2016) 0.75
Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment. J Am Soc Nephrol (2017) 0.75
The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function. BMC Nephrol (2015) 0.75
Determinants of intravascular resistance in Indian diabetic nephropathy patients: a hospital-based study. Int J Vasc Med (2011) 0.75
Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients: The first experience in Iran. J Res Med Sci (2015) 0.75
Serum cystatin C reflects the progress of albuminuria. Diabetes Metab J (2011) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc (1985) 7.02
Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis (2002) 6.52
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med (1996) 5.17
Cystatin C. Ann Clin Biochem (2002) 3.42
A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant (2003) 2.95
Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem (2002) 2.88
Cystatin C--a new marker of glomerular filtration rate in children independent of age and height. Pediatrics (1998) 2.50
Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest (1999) 2.27
Serum cystatin C as an endogenous marker of the renal function--a review. Clin Chem Lab Med (1999) 2.05
Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int (2002) 1.96
Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int (2002) 1.61
Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med (1985) 1.60
How to assess glomerular function and damage in humans. J Hypertens (1999) 1.45
Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol (1996) 1.43
Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care (2002) 1.39
Progression of overt nephropathy in non-insulin-dependent diabetes. Kidney Int (1995) 1.30
Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med (2001) 1.26
Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest (1991) 1.25
Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol (2000) 1.24
Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol Cooperative Study Group. Ann Pharmacother (1998) 1.22
Developments in the assessment of glomerular filtration rate. Clin Chim Acta (2000) 1.18
Application of newer clearance techniques for the determination of glomerular filtration rate. Curr Opin Nephrol Hypertens (1998) 1.10
Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron (2002) 1.06
Commentary: clinical diagnostic use of cystatin C. J Clin Lab Anal (2004) 1.04
Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens (2001) 0.99
Serum cystatin C assay for the detection of early renal impairment in diabetic patients. J Clin Lab Anal (2004) 0.97
How to protect the kidney in diabetic patients: with special reference to IDDM. Diabetes (1997) 0.92
Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjects. Diabetes Metab (2003) 0.89
Mechanism of glomerular hyperfiltration after a protein meal in humans. Role of hormones and amino acids. Diabetes Care (1994) 0.86
Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystatin C. Clin Chem Lab Med (1998) 0.86
Natural history and pathogenesis of diabetic nephropathy. J Diabet Complications (1992) 0.85
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet (2008) 7.71
Regression of microalbuminuria in type 1 diabetes. N Engl J Med (2003) 7.67
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol (2007) 4.48
A transcriptional profile of aging in the human kidney. PLoS Biol (2004) 3.69
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes (2009) 3.16
Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol (2006) 3.12
Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int (2012) 2.97
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest (2011) 2.90
In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int (2010) 2.82
Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol (2012) 2.75
Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol (2012) 2.58
Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol (2003) 2.55
Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol (2011) 2.50
A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes (2002) 2.15
High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care (2010) 2.12
Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes (2008) 2.07
Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA (2006) 2.07
Podocytopenia and disease severity in IgA nephropathy. Kidney Int (2002) 1.98
Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol (2007) 1.92
Effects of aging on glomerular function and number in living kidney donors. Kidney Int (2010) 1.92
Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care (2007) 1.92
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes. JAMA (2008) 1.88
Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies. Diabetes (2008) 1.82
Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int (2010) 1.81
Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy. Diabetes (2009) 1.80
Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes (2007) 1.79
New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79
Genetic analysis of albuminuria in aging mice and concordance with loci for human diabetic nephropathy found in a genome-wide association scan. Kidney Int (2009) 1.78
High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol (2008) 1.74
Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71
Debate: PRO Position. Formal assessment of donor kidney function should be mandatory. Am J Nephrol (2011) 1.70
Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney Int (2010) 1.67
Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care (2013) 1.62
Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol (2008) 1.62
The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J Clin Invest (2010) 1.61
Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes (2007) 1.61
Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes (2007) 1.58
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol (2009) 1.57
Changing patterns of type 2 diabetes incidence among Pima Indians. Diabetes Care (2007) 1.55
Determinants of glomerular hypofiltration in aging humans. Kidney Int (2003) 1.54
Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation (2002) 1.52
An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetic patients. Kidney Int (2008) 1.51
Periodontal disease and mortality in type 2 diabetes. Diabetes Care (2005) 1.48
Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care (2003) 1.46
Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int (2005) 1.45
Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol (2008) 1.44
A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes. Diabetes (2006) 1.43
Testing for microalbuminuria in 2002: barriers to implementing current guidelines. Am J Kidney Dis (2003) 1.43
Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes. Am J Kidney Dis (2008) 1.39
Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes (2012) 1.39
Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci U S A (2003) 1.35
Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23. Diabetes (2004) 1.34
Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes (2005) 1.34
Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab (2004) 1.34
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation (2015) 1.33
Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes (2002) 1.32
The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Kidney Int (2012) 1.32
Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis (2005) 1.32
Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care (2007) 1.32
Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes (2007) 1.29
Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci (2008) 1.29
Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. Diabetes Care (2012) 1.26
The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol (2008) 1.22
Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin J Am Soc Nephrol (2011) 1.20
Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. Proc Natl Acad Sci U S A (2009) 1.17